[Transmission of human immunodeficiency virus to the fetus during pregnancy]

Presse Med. 1996 Jan 27;25(3):119-25.
[Article in French]

Abstract

Estimates of the rate of human immunodeficiency virus vertical transmission range from 15% to 40%, and the rate is lower in European and American studies than in African studies. There appears to be a relationship between maternal factors, mode of delivery and mother-to-child transmission. The risk factors or markers associated with increased vertical transmission are analyzed in this review. The use of zidovudine, administered to HIV-infected women during pregnancy and labour, and to the offspring for 6 weeks reduce the mother-to-infant transmission rate from 25% to 8%. Other strategies to alter transmission of HIV, including the use of combinaison of anti-retroviral drugs, immunoprophylaxis against HIV or obstetric interventions needs to be evaluated.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antimetabolites / therapeutic use
  • Female
  • HIV Infections / prevention & control
  • HIV Infections / therapy
  • HIV Infections / transmission*
  • Humans
  • Infant, Newborn
  • Male
  • Maternal-Fetal Exchange
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control
  • Pregnancy Complications, Infectious / therapy
  • Pregnancy Complications, Infectious / virology*
  • Prenatal Diagnosis
  • Prognosis
  • Risk Factors
  • Zidovudine / therapeutic use

Substances

  • Antimetabolites
  • Zidovudine